Both delivery forms produce meaningful weight loss when taken as directed
For those using GLP-1s for weight loss, experts say the AMD findings are even less likely to apply
However, because GLP-1 is being considered for long-term use, its essential to weigh the safety data carefully
According to recently published clinical research by Galderma in January 2025, patients using GLP-1 medications frequently report significant facial alterations: Loss of facial volume creating shadowing and hollowness Increased skin laxity and sagging Changes in facial structure and balance Skin appearing less radiant and drier An overall aged appearance beyond their chronological age Dr
Baseline Biomarker Assessment: The Foundation for Safe Dual Therapy Before starting testosterone with a GLP-1 medication, comprehensive baseline bloodwork should include: testosterone, estradiol, FSH/LH, fasting glucose, HbA1c, lipid panel, liver and kidney function, hematocrit, and thyroid markers
Procedural expertise: URS, PCNL, RIRS, TURP, TURBT, and major open urological surgery